Publication | Open Access

Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis

MedicineImmunologyMulti-institutional AnalysisImmune Checkpoint InhibitorBronchial NeoplasmCancer TreatmentImmunotherapyOncologyImmune-related Adverse EventsLong-term OutcomesLung Cancer